Clinical Trials Update: Oct. 13, 2006
Vaccines Vaginal Atrophy Celiac Disease
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Healthy adults are wanted to participate in this clinical research trial of an investigational flu vaccine. Participants must be at least 65 years old and be in good health.
The research site is in Pittsburgh, Penn.
This clinical study seeks post-menopausal women, ages 30 to 80, to evaluate an investigational hormone in the form of a vaginal cream to treat vaginal atrophy. Participants will receive study-related exams and investigational medication at no cost and may be compensated up to $440 for time and travel.
The research site is in Overland Park, Kan.
This study will evaluate the safety, effectiveness, and tolerability of a drug called AT1001 in people with celiac disease. Volunteers 18-65 with a diagnosis of celiac disease by biopsy for at least six months (attending physician confirmation will be accepted in lieu of a biopsy report), and who have been on a gluten-free diet for at least the past six months may qualify. People with chronic active GI disease other than celiac disease (i.e., IBS, Crohn's, Colitis), or who have diabetes (type 1 or type 2) will not be eligible.
The research sites are located across the United States.
Copyright 2006 Thomson CenterWatch. All rights reserved.